|
|
||||||||

* Department of Immunology, Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris France; and
Institut Nationale de la Santé et de la Recherche Médicale Unité 818, Paris, France
The CNS is considered immune privileged due to the blood-brain barrier and the absence of conventional lymphatics. Nonetheless, T cell immune responses specific for CNS Ag have been documented. Where these events are initiated and what cellular mechanisms are involved remain unknown. In this study, we established an experimental mouse model to evaluate the requirements for priming CD8+ T cells following the cross-presentation of intracranial Ag. Surprisingly, we find that even with a damaged blood-brain barrier, Ag presentation occurs in regional lymph nodes and not within the CNS itself. Only once the responding cells have expanded can they traffic to the site of CNS injury. Cross-presentation of intracranial Ag is efficient and the subsequent priming of CD8+ T cells is dependent on CD4+ T cell help and CD40 signaling in host APCs. Our findings have important implications for the initiation of T cell immune responses toward CNS Ags.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by The European Young Investigator Award Scheme, European Science Foundation (to M.L.A.) and the European Molecular Biology Organization Long-Term Fellowship (to L.W.).
2 Address correspondence and reprint requests to Dr. Matthew L. Albert, Department of Immunology, Institut Pasteur, 25, Rue du Dr. Roux, Paris, France 75724. E-mail address: albertm{at}pasteur.fr
3 Abbreviations used in this paper: IC, intracranial(ly); DC, dendritic cell; LN, lymph node; WT, wild type; IF, intrafootpad.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |